Skip to content

NIRF Trial: Near-Infrared Spectroscopy for Intraoperative Restriction of Fluids Trial

Near-Infrared Spectroscopy for Intraoperative Restriction of Fluids Trial A Prospective Randomized Study of Near-infrared Spectroscopy Directed Fluid Therapy vs Standard Fluid Therapy in Patients Undergoing Open Elective Colorectal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00731978
Acronym
NIRF
Enrollment
27
Registered
2008-08-11
Start date
2008-09-30
Completion date
2009-10-31
Last updated
2009-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Surgery

Keywords

Near-Infrared Spectroscopy, Intraoperative Care

Brief summary

The purpose of this study is to evaluate if the InSpectra StO2 Monitor can safely guide the amount of fluid needed during colorectal surgery. The study hypothesis is that intraoperative fluid limitation can be safely accomplished when guided by StO2 monitoring, and that this fluid restriction regimen will result in a reduction in postoperative morbidity when compared to standard monitoring and fluid therapy.

Interventions

PROCEDURERestricted intraoperative fluid management

Intraoperative fluid management guided by Sto2.

Sponsors

Hutchinson Technology Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled for elective open colorectal surgery * Age greater than or equal to 18 years * Low to moderate risk colorectal surgery patients

Exclusion criteria

* Unacceptable Baseline vital sign measurements * High risk colorectal surgery patients * Jehovah's Witness

Design outcomes

Primary

MeasureTime frame
Major postoperative complicationswithin the first 30 days of the postoperative period

Secondary

MeasureTime frame
StO2 changes during intraoperative fluid management, hospital-free days, surgical site infections, time to first bowel movement, total fluid and total intraoperative fluid volumes, daily fluid volumes through 3 days postoperative, daily weightswithin the first 30 days of the postoperative period

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026